+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Polymorphisms in the DNA repair gene XRCC1 and survival of non-small cell lung cancer



Polymorphisms in the DNA repair gene XRCC1 and survival of non-small cell lung cancer



Journal of Clinical Oncology 23(16_Suppl): 9585-9585



NlmCategory="UNASSIGNED">9585 Background: X-ray cross-complementing group 1 (XRCC1) protein is known to be mainly involved in BER(base excision repair) of DNA repair process. We investigated the association of three polymorphisms (codon 194, 280, and 399) of XRCC1 with lung cancer, whether these polymorphisms have an effect on survival of lung cancer patients received radiotherapy. 229 lung cancer patients with NSCLC in stage I-IV were recruited at Asan Medical Center and followed up at least every 3 months from the time of study entry. Genotyping was performed by single base primer exclusion assay using SNapShot Kit with blood samples from all patients. Kaplan-Meier survival curve was used for polymorphism effect on progression-free and overall survival. Hazard ratio by Cox-proportional hazard regression was calculated after adjustment for age, gender, histology, stage, and alcohol consumption. These variables were selected through the univariate analysis performed previously. The haplotype of XRCC1 polymorphisms was estimated by PHASE version 2.1. The subjects were consisted of 191(83.4%) males and 38(16.6%) females. The median age was 62 (range 26 - 88) and 60% of patients were included in stage I-IIIa. More than 85% of patients had squamous cell carcinoma and adenocarcinoma. The mean survival time was 20.2 months and 22.5 months in progression-free and overall survival, respectively. XRCC1 codon 194, histology, and stage were shown to be a significant predictor in progression-free survival and alcohol consumption seemed to have protective effect significantly (p=0.028). The six haplotypes among XRCC1 polymorphisms (194, 280, and 399) were estimated by PHASE v.2.1. The patients with the haplotype pairs other than homozygous TGG haplotype pairs seemed to survive longer significantly compared with those with them (p=0.04). In the present study, we suggest that polymorphisms of XRCC1 have an effect on survival of lung cancer patients treated with radiotherapy and the effect appears more strongly considering haplotype pairs. No significant financial relationships to disclose.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058571745

Download citation: RISBibTeXText

PMID: 27944059


Related references

DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival. Cellular Physiology and Biochemistry 36(4): 1419-1429, 2015

An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Molecular Biology Reports 38(8): 5231-5241, 2011

Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer. International Journal of Clinical and Experimental Pathology 8(4): 4171-4176, 2015

Association between polymorphisms in the XRCC1 gene and the risk of non-small cell lung cancer. Genetics and Molecular Research 14(4): 12888-12893, 2015

No association between the XPD 312, 751, or XRCC1 399 polymorphisms and K-ras gene mutation in smoking non-small-cell lung cancer. Cancer Epidemiology Biomarkers and Prevention 13(4): 673-675, 2004

Polymorphisms and haplotypes in the XRCC1 gene and the risk of advanced non-small cell lung cancer. Journal of Thoracic Oncology 5(12): 1912-1921, 2010

No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy. Cancer Biology and Therapy 10(9): 854-859, 2010

Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer. Cancer Science 101(11): 2436-2442, 2010

Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. Plos one 9(6): E99843, 2014

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients. Cancer Medicine 5(9): 2332-2342, 2016

Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer. Genetics and Molecular Research 14(3): 10331-7, 2015

Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention 10(2): 119-123, 2001

Polymorphisms of the DNA repair gene XRCC1 and the risk of lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting (41): 320, 2000

GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer. Genetics and Molecular Research 15(2):, 2016

Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics. Genetics and Molecular Research 15(4):, 2016